Where we concentrate
When depression has continued despite treatment
When previous depression treatments have not helped enough, we review the history and discuss appropriate options. Spravato (esketamine) is an FDA-approved treatment for treatment-resistant depression in adults and is provided in a certified healthcare setting.
Eligible patients receive Spravato here under supervision, with monitoring for at least two hours after each dose. An evaluation determines whether it is a suitable option.
How Spravato® works here